4//SEC Filing
Duchemin Jeffrey 4
Accession 0001209191-19-000905
CIK 0001123494other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:12 PM ET
Size
5.6 KB
Accession
0001209191-19-000905
Insider Transaction Report
Form 4
Duchemin Jeffrey
Chief Executive Officer
Transactions
- Tax Payment
Common Stock
2019-01-01$3.18/sh−61,755$196,381→ 680,494 total
Footnotes (2)
- [F1]The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with deferred stock awards previously granted to the Reporting Person which vested in part on January 1, 2019.
- [F2]Includes (a) a deferred stock award of 94,444 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; (b) a deferred stock award of 70,833 restricted stock units which shall vest in three equal installments on January 1, 2020, 2021 and 2022; (c) a deferred stock award of 178,804 restricted stock units which shall vest in three equal installments on January 1, 2020 and 2021; (d) a deferred stock award of 72,916 restricted stock units which shall vest on January 1, 2020; and (e) 263,497 shares of common stock held by the Reporting Person.
Documents
Issuer
HARVARD BIOSCIENCE INC
CIK 0001123494
Entity typeother
Related Parties
1- filerCIK 0001585223
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:12 PM ET
- Size
- 5.6 KB